These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1689610)

  • 1. Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.
    Wassermann K; Zwelling LA; Lown JW; Hartley JA; Nishikawa K; Lin JR; Newman RA
    Cancer Res; 1990 Mar; 50(6):1732-7. PubMed ID: 1689610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
    Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of hyperthermia with bleomycin and liblomycin: effects on CHO cells in vitro.
    Dogramatzis D; Nishikawa K; Newman RA
    Anticancer Res; 1991; 11(3):1359-64. PubMed ID: 1716087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
    Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of fluoromycin: a novel fluorescence-labeled derivative of talisomycin S10b.
    Mistry JS; Jani JP; Morris G; Mujumdar RB; Reynolds IJ; Sebti SM; Lazo JS
    Cancer Res; 1992 Feb; 52(3):709-18. PubMed ID: 1370650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line.
    Kim HK; Zwelling LA; Sacks PG; Hong WK; Chan D; Silberman L; Glisson BS
    Cancer Res; 1989 Mar; 49(5):1197-201. PubMed ID: 2537145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Damage and repair induced by bleomycin in the domain of human amplified MYC oncogenes.
    Bianchi NO; Bianchi MS; López-Larraza D; Alitalo K; de la Chapelle A
    Cancer Res; 1990 Apr; 50(8):2379-84. PubMed ID: 1690597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial single-strand DNA damage and cellular pharmacokinetics of bleomycin A2.
    Lazo JS; Schisselbauer JC; Meandzija B; Kennedy KA
    Biochem Pharmacol; 1989 Jul; 38(13):2207-13. PubMed ID: 2472141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular DNA strand scission and growth inhibition of Ehrlich ascites tumor cells by bleomycins.
    Byrnes RW; Templin J; Sem D; Lyman S; Petering DH
    Cancer Res; 1990 Sep; 50(17):5275-86. PubMed ID: 1696848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
    Long BH; Musial ST; Brattain MG
    Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of bleomycin, neocarzinostatin, and auromomycin cleavage of cell-free and intracellular simian virus 40 DNA and chromatin.
    Grimwade JE; Beerman TA
    Mol Pharmacol; 1986 Oct; 30(4):358-63. PubMed ID: 2429169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitive Chinese hamster ovary cell lines.
    Robson CN; Hoban PR; Harris AL; Hickson ID
    Cancer Res; 1987 Mar; 47(6):1560-5. PubMed ID: 2434220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth.
    Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R
    Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
    Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
    Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic cytotoxicity and DNA strand break formation by bromodeoxyuridine and bleomycin in human tumor cells.
    Ackland SP; Schilsky RL; Beckett MA; Weichselbaum RR
    Cancer Res; 1988 Aug; 48(15):4244-9. PubMed ID: 2455593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity to bleomycin of human cultured tumor cells and analysis of related factors].
    Urade M; Sugi M; Shirasuna K; Sugiyama M; Miyazaki T
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2382-8. PubMed ID: 6195972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection and characterization of a bleomycin-resistant subline of B16 melanoma.
    Zuckerman JE; Raffin TA; Brown JM; Newman RA; Etiz BB; Sikic BI
    Cancer Res; 1986 Apr; 46(4 Pt 1):1748-53. PubMed ID: 2418953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repair of bleomycin-induced DNA double-strand breakage in Ehrlich ascites tumor cells.
    Byrnes RW; Petering DH
    Radiat Res; 1993 Jun; 134(3):343-8. PubMed ID: 7686298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
    Sebti SM; Jani JP; Mistry JS; Gorelik E; Lazo JS
    Cancer Res; 1991 Jan; 51(1):227-32. PubMed ID: 1703034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between sites of binding to DNA and strand cleavage for complexes of bleomycin with iron or cobalt.
    McLean MJ; Dar A; Waring MJ
    J Mol Recognit; 1989 Apr; 1(4):184-92. PubMed ID: 2483675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.